CELG

Celgene Corporation News Headlines

$141.51
*  
0.35
 negative 
0.25%
Get CELG Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Investing In Cancer Research Is Worth The Risk: Echo He
5/24/2013 11:59:00 AM - Seeking Alpha

Priority FDA Review for Celgene's Abraxane - Analyst Blog
5/24/2013 11:28:02 AM - Zacks.com

Encouraging News for Peregrine Pharma - Analyst Blog
5/23/2013 7:26:41 PM - Zacks.com

NPS Pharma Prices Offering - Analyst Blog
5/23/2013 7:25:47 PM - Zacks.com

Cramer's Mad Money - The Miraculous Six Flags (5/22/13)
5/23/2013 6:56:00 AM - Seeking Alpha

Gilead's Sofosbuvir under European Review - Analyst Blog
5/22/2013 4:27:00 PM - Zacks.com

Market Close Report: NASDAQ Composite index closes at 3,465.24 down -6.38 points
5/16/2013 4:45:13 PM - NASDAQ.com News

Myriad Soars Higher on Celeb Clout - Analyst Blog
5/15/2013 2:27:06 PM - Zacks.com

Wider-Than-Expected Loss at Athersys - Analyst Blog
5/15/2013 10:29:34 AM - Zacks.com

Celgene Attains 52-Week High - Analyst Blog
5/14/2013 1:07:16 PM - Zacks.com

Celgene: Apremilast For Psoriatic Arthritis Offers Upside
5/14/2013 12:50:00 PM - Seeking Alpha

NPS Pharma Incurs Narrower 1Q Loss - Analyst Blog
5/14/2013 10:23:01 AM - Zacks.com

Setback for Endo Health on Opana ER - Analyst Blog
5/13/2013 6:05:22 PM - Zacks.com

Genomic Gains Coverage for DCIS - Analyst Blog
5/13/2013 3:17:06 PM - Zacks.com

Earnings Beat at Warner Chilcott - Analyst Blog
5/13/2013 10:48:01 AM - Zacks.com

Part 2: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company?
5/12/2013 6:21:00 PM - Seeking Alpha

Part 1: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company?
5/12/2013 6:06:00 PM - Seeking Alpha

After Hours Most Active for May 10, 2013 : HAL, BAC, GM, SINA, QQQ, LYB, PCG, SYMC, DDD, CELG, INTC, ICON
5/10/2013 4:44:02 PM - NASDAQ.com News

Positive Data on Celgene's Apremilast - Analyst Blog
5/9/2013 4:23:59 PM - Zacks.com

Narrower Loss from Onyx, Guidance Maintained - Analyst Blog
5/8/2013 6:25:08 PM - Zacks.com

Good News for Bristol-Myers - Analyst Blog
5/6/2013 4:23:33 PM - Zacks.com

Cramer's Mad Money - 10 Things To Watch In The Week Ahead (5/3/13)
5/5/2013 6:59:00 AM - Seeking Alpha

Eylea Drives Earnings at Regeneron - Analyst Blog
5/3/2013 2:35:14 PM - Zacks.com

Mylan Reports in line Earnings - Analyst Blog
5/3/2013 8:31:34 AM - Zacks.com

Biotechnology: Strong Fundamentals Are The Basis Of Strong Performance
5/3/2013 5:59:00 AM - Seeking Alpha